Premium
Oncogene mutation and prognosis in the myelodysplastic syndromes
Author(s) -
Padua R. A.,
West R. R.
Publication year - 2000
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2000.02472.x
Subject(s) - myelodysplastic syndromes , medicine , mutation , international prognostic scoring system , oncogene , oncology , cancer research , cancer , genetics , biology , gene , bone marrow , cell cycle
In a series of myelodysplastic syndrome patients, mutational status (particularly RAS mutation) was found to be prognostic for survival, independently of four previously reported scoring systems (Bournemouth, Sanz, Lille, International).